Filing Flows › Biomerica (BMRA) › How it makes money
How Biomerica (BMRA) makes money
Biomerica (BMRA) made $1.3M of revenue in the first quarter fiscal 2027 (Q1 FY27), -8% from a year earlier. Clinical Lab brought in $775K (61%); Over-the-counter brought in $291K (23%); Contract Manufacturing brought in $197K (16%).
Drawing the Sankey…
Revenue by segment, Q1 FY27
| Segment | Revenue | Share | Q/Q | Y/Y |
|---|---|---|---|---|
| Clinical Lab | $775K | 61.3% | +89% | -24% |
| Over-the-counter | $291K | 23.0% | +185% | +81% |
| Contract Manufacturing | $197K | 15.6% | -45% | +3% |
| Physician's Office | $2K | 0.2% | -33% | -33% |
Where each dollar of revenue goes
| Line | Q1 FY27 | % of revenue |
|---|---|---|
| Revenue | $1.3M | 100.0% |
| Income tax | $6K | 0.5% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q1 FY27 | $1.3M | -8% |
| Q4 FY26 | $875K | +17% |
| Q3 FY26 | $987K | -12% |
| Q2 FY26 | $1.2M | -26% |
| Q1 FY26 | $1.4M | -24% |
| Q4 FY25 | $749K | -33% |
| Q3 FY25 | $1.1M | +10% |
From Biomerica's 10-Q filed Oct 15, 2026 (on EDGAR).
Questions
How does Biomerica make money?
Biomerica (BMRA) made $1.3M of revenue in the first quarter fiscal 2027 (Q1 FY27), -8% from a year earlier. Clinical Lab brought in $775K (61%); Over-the-counter brought in $291K (23%); Contract Manufacturing brought in $197K (16%).
What is Biomerica's biggest business?
Clinical Lab: $775K in the first quarter fiscal 2027, 61% of revenue, -24% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.